A high growth, high multiple, small-cap healthcare service company was struggling with quarterly results and the implications to the current financial outlook. This was the first quarter as a public company that would be below Wall Street’s expectations. The company wanted assistance in crafting the message for the quarter and a future growth strategy.
A few quarters after a product launch, a public specialty pharmaceutical company was struggling to meet Wall Street expectations, as the covering sell-side analysts continued to be overly optimistic with sales estimates. To that date, the company had not provided any financial guidance.